Pyroptotic cell-derived microparticle: An atherogenic factor in infectious diseases

Area of Science:

• Immunology
• Cardiovascular Science
• Cell Biology

Background:

• Chronic infections are linked to atherosclerosis development.
• Infectious agents trigger pyroptosis, a form of inflammatory programmed cell death.
• Pyroptotic cells are found in atherosclerotic lesions, suggesting a role in the disease.

Purpose of the Study:

• To investigate the role of pyroptotic cell-derived microparticles in atherosclerosis.
• To test the hypothesis that these microparticles are atherogenic factors in infectious diseases.

Main Methods:

• Analysis of pyroptotic cells and their microparticle release in atherosclerotic lesions.
• Investigating the impact of microparticles on endothelial cells, macrophages, and vascular smooth muscle cells.

Main Results:

• Pyroptosis is induced by infectious agents and occurs in atherosclerotic lesions.
• Microparticles released during pyroptosis transfer inflammatory mediators.
• These microparticles mediate cell-cell interactions, causing endothelial injury and promoting atherosclerotic progression.

Conclusions:

• Pyroptotic cell-derived microparticles are a significant atherogenic factor in infectious diseases.
• Targeting pyroptosis or its microparticle release may offer therapeutic strategies for atherosclerosis.